Pfizer Files Lasofoxifene NDA For Treatment Of Osteoporosis
This article was originally published in The Pink Sheet Daily
Executive Summary
Selective estrogen receptor modulator now is called Fablyn rather than Oporia, a name under which it received two “not approvable” letters.